Health ❯ Healthcare ❯ Pharmaceuticals

Biosimilars

Drug Approval Regulatory Approvals Cancer Treatment Tyruko Stelara Biosimilar Drugs Keytruda Insulin Glargine User Fees Ustekinumab Drug Pricing Regulatory Changes FDA Approval Process Enzeevu™ FDA Guidance Regulations Insulin Starjemza Respiratory Drugs Gotenfia Pertuzumab-dpzb Teva Pharmaceuticals Nufymco Product Portfolio Immuno-Oncology Regulatory Guidance Ophthalmology Rheumatoid Arthritis Treatments

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

The licensing deal makes Zydus the U.S. marketer and keeps Bioeq responsible for manufacturing and supply.

FDA Approves Poherdy as First Interchangeable Biosimilar to Perjeta for HER2-Positive Breast Cancer